141 related articles for article (PubMed ID: 10377757)
1. Genetic and hormonal regulation of murine hepatocarcinogenesis.
Chiaverotti T; Carabeo R; Drinkwater N
Prog Exp Tumor Res; 1999; 35():131-42. PubMed ID: 10377757
[No Abstract] [Full Text] [Related]
2. Hormonal and genetic interactions in murine hepatocarcinogenesis.
Poole TM; Drinkwater NR
Prog Clin Biol Res; 1995; 391():187-94. PubMed ID: 8532716
[No Abstract] [Full Text] [Related]
3. [Pathogenesis of human cancer].
Kitagawa T
Hum Cell; 1991 Mar; 4(1):1-12. PubMed ID: 1653595
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of multistage hepatocarcinogenesis.
Poole TM; Chiaverotti TA; Carabeo RA; Drinkwater NR
Prog Clin Biol Res; 1996; 395():33-45. PubMed ID: 8895982
[No Abstract] [Full Text] [Related]
5. Comparative molecular pathogenesis of hepatocellular carcinomas.
Hino O; Kitagawa T; Nomura K; Ohtake K; Yasui H; Okamoto N; Hirayama Y
Prog Clin Biol Res; 1992; 376():173-85. PubMed ID: 1326769
[No Abstract] [Full Text] [Related]
6. Mouse models to study the interaction of risk factors for human liver cancer.
Sell S
Cancer Res; 2003 Nov; 63(22):7553-62. PubMed ID: 14633666
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B infection and the pathogenesis of hepatocellular carcinoma.
Thiele DL
Gastroenterology; 1990 Jun; 98(6):1711-2. PubMed ID: 2338205
[No Abstract] [Full Text] [Related]
8. Cell biology of hepatocarcinogenesis.
Saeter G; Seglen PO
Crit Rev Oncog; 1990; 1(4):437-66. PubMed ID: 1964598
[No Abstract] [Full Text] [Related]
9. Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background.
Chung SI; Moon H; Kim DY; Cho KJ; Ju HL; Kim DY; Ahn SH; Han KH; Ro SW
BMC Gastroenterol; 2016 Jan; 16():13. PubMed ID: 26821924
[TBL] [Abstract][Full Text] [Related]
10. [Sirtuin 1, hepatic steatosis and liver cancer].
Gilgenkrantz H; Perret C
Med Sci (Paris); 2012 Mar; 28(3):269-71. PubMed ID: 22480650
[No Abstract] [Full Text] [Related]
11. Human and mouse hepatocellular adenoma and carcinoma display similar tumorigenesis pathway alterations.
Zucman-Rossi J
J Hepatol; 2008 May; 48(5):884-6. PubMed ID: 18314218
[No Abstract] [Full Text] [Related]
12. Two genes abrogate the inhibition of murine hepatocarcinogenesis by ovarian hormones.
Poole TM; Drinkwater NR
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5848-53. PubMed ID: 8650181
[TBL] [Abstract][Full Text] [Related]
13. [Hepatitis B virus and hepatocellular carcinoma: the track of chromosome X].
Ratziu V
Gastroenterol Clin Biol; 1993; 17(4):314-6. PubMed ID: 8393413
[No Abstract] [Full Text] [Related]
14. Functional inactivation but not structural mutation of p53 causes liver cancer.
Ueda H; Ullrich SJ; Gangemi JD; Kappel CA; Ngo L; Feitelson MA; Jay G
Nat Genet; 1995 Jan; 9(1):41-7. PubMed ID: 7704023
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice.
Ghebranious N; Sell S
Hepatology; 1998 Feb; 27(2):383-91. PubMed ID: 9462635
[TBL] [Abstract][Full Text] [Related]
16. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mouse models and hepatocellular carcinoma: future prospects.
Lakhtakia R; Panda SK
Trop Gastroenterol; 2000; 21(3):91-4. PubMed ID: 11084827
[No Abstract] [Full Text] [Related]
18. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
19. [Hepatitis B virus and hepatocellular carcinoma].
Tiollais P; Dejean A; Buendia MA
Bull Acad Natl Med; 1991 Feb; 175(2):263-71; discussion 271-2. PubMed ID: 1650625
[TBL] [Abstract][Full Text] [Related]
20. Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology.
Chen CJ; Chen DS
Hepatology; 2002 Nov; 36(5):1046-9. PubMed ID: 12395312
[No Abstract] [Full Text] [Related]
[Next] [New Search]
